5-fluorouracil Market Is Anticipated To Register Around 8.3% CAGR From 2022-2031
The 5-fluorouracil market is expected to grow at a CAGR of over 8.3% from 2022 to 2031. This growth is attributed to the increasing prevalence of cancer and the rising demand for effective treatments. 5-fluorouracil is a chemotherapy drug used to treat various types of cancer, including breast, stomach, and colorectal cancer. The growing availability of generic drugs is one of the major factors driving the growth of the 5-fluorouracil market. Generic drugs are cheaper than their brand-name counterparts and offer the same efficacy and safety. The rising cost of treatment is one of the major challenges facing the 5-fluorouracil…
- Date: November 17, 2022
- Author: Quintero
- Category: PharmiWeb